The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience

Factors influencing immunologic response to hepatitis B vaccine in adults

(2016) Shigui Yang et al.   Scientific Reports

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus

(2016) Olivier Van Der Meeren et al.   Human Vaccines & Immunotherapeutics

Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults

(2016) Huai Wang et al.   Human Vaccines & Immunotherapeutics

Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases

(2015) Arthur Belle et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus

(2015) Julia M. Janssen et al.   VACCINE

Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis

(2015) Olivier Van Der Meeren et al.   Human Vaccines & Immunotherapeutics

Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives

(2014) Wolfram H. Gerlich   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients

(2014) Christopher L. Gilbert et al.   VACCINE

Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?

(2013) J D Ni et al.   INTERNATIONAL JOURNAL OF STD & AIDS

High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees

(2013) Angelique P.A. Vermeiren et al.   JOURNAL OF CLINICAL VIROLOGY

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age

(2013) William L. Heyward et al.   VACCINE

Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease

(2012) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy of Hepatitis B Vaccination and Revaccination and Factors Impacting on Response in Patients With Inflammatory Bowel Disease

(2012) J P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of HBV Vaccination in Various Stages of Chronic Kidney Disease: Is Earlier Better?

(2012) Behnam Hashemi et al.   Hepatitis Monthly

Immunogenicity of different hepatitis B virus vaccination schedules in liver transplant recipients

(2012) Lijuan Feng et al.   HEPATOLOGY RESEARCH

Efficacy of a Hepatitis B Vaccination Schedule With Two Cycles of Four Double Doses of Conventional Vaccine and Four Doses of Adjuvanted Vaccine in Chronic Kidney Disease Patients Evaluated for Renal Transplantation

(2012) R. García-Agudo et al.   TRANSPLANTATION PROCEEDINGS

Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine

(2012) Benjamin P. Sablan et al.   VACCINE

Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders

(2012) Christian J.P.A. Hoebe et al.   VACCINE

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity

(2011) Adrian Cassidy et al.   Expert Review of Vaccines

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥ 50 years

(2011) Christopher L. Gilbert et al.   Human vaccines & immunotherapeutics

Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens

(2011) Patricia M Flynn et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Nucleic Acid Testing to Detect HBV Infection in Blood Donors

(2011) Susan L. Stramer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients

(2011) Shih-Yi Lin et al.   VACCINE

Hepatitis B vaccination coverage among high-risk adults 18–49 years, U.S., 2009

(2011) Peng-jun Lu et al.   VACCINE

Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users

(2011) Thanh Q. Tran et al.   VACCINE

Correlates of Protection Induced by Vaccination

(2010) S. A. Plotkin   Clinical and Vaccine Immunology

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years

(2010) Miguel W. Tregnaghi et al.   VACCINE

Imunogenicidade da vacina brasileira contra hepatite B em adultos

(2010) José Cássio de Moraes et al.   REVISTA DE SAUDE PUBLICA

Compliance with and response to hepatitis B vaccination in remaining quilombo communities in Central Brazil

(2009) Ana Rita C. Motta-Castro et al.   Cadernos de Saude Publica

Association of Infectious Mononucleosis with Multiple Sclerosis

(2009) Sreeram V. Ramagopalan et al.   NEUROEPIDEMIOLOGY

Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand

(2009) Yong Poovorawan et al.   VACCINE

Hepatitis B vaccines: WHO position paper—Recommendations

(2009)   VACCINE

The global impact of vaccination against hepatitis B: A historical overview

(2008) Alessandro R. Zanetti et al.   VACCINE